Author Correction: Functional dissection of inherited non-coding variation influencing multiple myeloma risk

Ajore, Ram ¹ ; Niroula, Abhishek ²     ; Pertesi, Maroulio ¹     ; Cafaro, Caterina ¹ ; Thodberg, Malte ¹     ; Went, Molly ³ ; Bao, Erik L. ⁴     ; Duran-Lozano, Laura ¹ ; Lopez de Lapuente Portilla, Aitzkoa ¹ ; Olafsdottir, Thorunn ⁵     ; Ugidos-Damboriena, Nerea ¹ ; Magnusson, Olafur ⁵ ; Samur, Mehmet ⁶     ; Lareau, Caleb A. ⁴     ; Halldorsson, Gisli H. ⁵     ; Thorleifsson, Gudmar ⁵ ; Norddahl, Gudmundur L. ⁵ ; Gunnarsdottir, Kristbjorg ⁵ ; Försti, Asta ⁷     ; Goldschmidt, Hartmut ⁸     ; Hemminki, Kari ⁹ ; van Rhee, Frits ¹⁰ ; Kimber, Scott ³ ; Sperling, Adam S. ⁶     ; Kaiser, Martin ³     ; Anderson, Kenneth ⁶     ; Jonsdottir, Ingileif ⁵     ; Munshi, Nikhil ⁶     ; Rafnar, Thorunn ⁵     ; Waage, Anders ¹¹ ; Weinhold, Niels ¹² ; Thorsteinsdottir, Unnur ⁵ ; Sankaran, Vijay G. ¹³     ; Stefansson, Kari ⁵     ; Houlston, Richard ³     ; Nilsson, Björn <sup>2    

1</sup>  Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361) 
²  Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361); Broad Institute of Massachusetts Institute of Technology and Harvard University, Boston, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623) 
³  Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom (GRID:grid.18886.3f) 
⁴  Broad Institute of Massachusetts Institute of Technology and Harvard University, Boston, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623); Division of Hematology/Oncology, Boston Children’s Hospital, Harvard Medical School, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438); Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
⁵  deCODE Genetics/Amgen Inc., Reykjavik, Iceland (GRID:grid.421812.c) (ISNI:0000 0004 0618 6889) 
⁶  Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
⁷  German Cancer Research Center (DKFZ), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); Hopp Children’s Cancer Center, Heidelberg, Germany (GRID:grid.510964.f) 
⁸  University Hospital of Heidelberg, Department of Internal Medicine V, Heidelberg, Germany (GRID:grid.5253.1) (ISNI:0000 0001 0328 4908) 
⁹  German Cancer Research Center (DKFZ), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); Charles University in Prague, Faculty of Medicine and Biomedical Center in Pilsen, Prague, Czech Republic (GRID:grid.4491.8) (ISNI:0000 0004 1937 116X) 
¹⁰  Hopp Children’s Cancer Center, Heidelberg, Germany (GRID:grid.510964.f) 
¹¹  Norwegian University of Science and Technology, Department of Cancer Research and Molecular Medicine, Trondheim, Norway (GRID:grid.5947.f) (ISNI:0000 0001 1516 2393) 
¹²  German Cancer Research Center (DKFZ), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); University Hospital of Heidelberg, Department of Internal Medicine V, Heidelberg, Germany (GRID:grid.5253.1) (ISNI:0000 0001 0328 4908) 
¹³  Broad Institute of Massachusetts Institute of Technology and Harvard University, Boston, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623); Division of Hematology/Oncology, Boston Children’s Hospital, Harvard Medical School, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438); Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Harvard Stem Cell Institute, Cambridge, USA (GRID:grid.511171.2)